Literature DB >> 7570632

Immunogenicity of a disulphide-containing neurotoxin: presentation to T-cells requires a reduction step.

B Maillère1, G Mourier, M Hervé, J Cotton, S Leroy, A Ménez.   

Abstract

It is known that production in a host of antibodies against a protein is associated with various molecular events. These include the stimulation of specific T-lymphocytes, a step that implies the processing of the protein into peptides by various endosomal/lysosomal enzymes, such as cathepsins. Strikingly, however, we observed in vitro that cathepsins B and D have no degrading effect on toxin alpha from Naja nigricollis, a curaremimetic toxin of 61 amino acids and four disulphides. In sharp contrast, the enzymes exert an efficient cleavage of the toxin polypeptide chain once the toxin disulphides are reduced. We also found that the fully reduced toxin and the native toxin were presented with comparable efficiency to two different T-hybridomas by antigen-presenting cells (APC). Together, the data suggest that presentation of toxin fragments to T-cells requires a reduction step of toxin disulphides and, in agreement with previous findings, that this step may be achieved by APC. We wish to suggest that this phenomenon may commonly occur for any toxic proteins that contain disulphides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570632     DOI: 10.1016/0041-0101(94)00186-c

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  9 in total

1.  Permeability of Cyclic Peptide Macrocycles and Cyclotides and Their Potential as Therapeutics.

Authors:  Spiros Liras; Kim F Mcclure
Journal:  ACS Med Chem Lett       Date:  2019-06-14       Impact factor: 4.345

2.  Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.

Authors:  Jürgen K Willmann; Richard H Kimura; Nirupama Deshpande; Amelie M Lutz; Jennifer R Cochran; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2010-02-11       Impact factor: 10.057

3.  Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.

Authors:  Richard H Kimura; Zhen Cheng; Sanjiv Sam Gambhir; Jennifer R Cochran
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

4.  Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1.

Authors:  Christine Almunia; Marie Bretaudeau; Gerhard Held; Aurélie Babon; Charles Marchetti; Florence Anne Castelli; André Ménez; Bernard Maillere; Daniel Gillet
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

5.  A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules.

Authors:  Zachary R Crook; Emily Girard; Gregory P Sevilla; Morgan Merrill; Della Friend; Peter B Rupert; Fiona Pakiam; Elizabeth Nguyen; Chunfeng Yin; Raymond O Ruff; Gene Hopping; Andrew D Strand; Kathryn A K Finton; Margo Coxon; Andrew J Mhyre; Roland K Strong; James M Olson
Journal:  J Mol Biol       Date:  2020-04-15       Impact factor: 6.151

Review 6.  In vitro-engineered non-antibody protein therapeutics.

Authors:  Rudo Simeon; Zhilei Chen
Journal:  Protein Cell       Date:  2017-03-07       Impact factor: 14.870

7.  Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids.

Authors:  Silvia A Camperi; Gerardo Acosta; Gabriela R Barredo; Lucía C Iglesias-García; Cleópatra Alves da Silva Caldeira; María C Martínez-Ceron; Silvana L Giudicessi; Osvaldo Cascone; Fernando Albericio
Journal:  Toxicon X       Date:  2020-05-05

8.  Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.

Authors:  Sarah J Moore; Cheuk Lun Leung; Heidi K Norton; Jennifer R Cochran
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

9.  A Bioengineered Peptide that Localizes to and Illuminates Medulloblastoma: A New Tool with Potential for Fluorescence-Guided Surgical Resection.

Authors:  Shelley E Ackerman; Christy M Wilson; Suzana A Kahn; James R Kintzing; Darren A Jindal; Samuel H Cheshier; Gerald A Grant; Jennifer R Cochran
Journal:  Cureus       Date:  2014-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.